Publications by authors named "V A Masycheva"

Article Synopsis
  • The study aimed to investigate whether combining ridostin and tamiflu could enhance treatment and prophylaxis effects in mice infected with a dangerous strain of influenza (H5N1).
  • Mice were infected and treated in various ways (with either drug or both together) and were monitored for 16 days, focusing on survival rates, virus levels, and overall health.
  • The results showed that using both drugs together after infection improved survival rates and reduced virus levels in the lungs compared to the control group.
View Article and Find Full Text PDF

Aim: Evaluation of composite formulation of yeast double stranded RNA with polyglucinum (dsRNA-PG) effect on non-specific antiviral resistance factors in mice in comparison with commercial formulation Ridostin.

Materials And Methods: dsRNA and Ridostin formulations were injected intramuscularly once at the dose of 5 mg/ml, polyglucinum--at the dose of 3.75 mg/ml.

View Article and Find Full Text PDF

Antitumor activity of TNF-α incorporated in nanoparticles (VLP-TNF-α) and dynamics of its accumulation and elimination from the blood and tumor tissue were studied in ICR mice. The VLP-TNF-α preparation exhibited higher antitumor activity compared to free TNF-α, presumably due to longer circulation of the cytokine in the blood and its more intensive accumulation by tumor tissue.

View Article and Find Full Text PDF

Cytotoxic properties of a liposomal form of the HLDF6 hexapeptide, representing an HL-60 cell differentiation factor fragment, have been studied on a murine primary lymphosarcoma cell culture. It is established that the liposomal HLDF6 peptide is capable of inhibiting proliferation and enhancing death of the cells of both LS and RLS lymphosarcoma strains distinguished by their sensitivity to cytostatic agents. The effect of the preparation is determined by its antiproliferative and apoptogenic actions on the cells.

View Article and Find Full Text PDF

A six-member HLDF6 peptide, fragment of HL-60 cell differentiation factor, exhibited antimetastatic and immunomodulating effects.

View Article and Find Full Text PDF